Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-09-18

Clinical Trial Update: Comparing Highly Purified hMG With Recombinant FSH + Recombinant LH in Women Undergoing Intrauterine Insemination. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Highly Purified human menopausal gonadotropin (hMG) with recombinant FSH plus recombinant LH for ovarian stimulation before intrauterine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Highly Purified hMG (human menopausal gonadotropin (hMG))
  • Recombinant FSH + Recombinant LH (recombinant FSH and recombinant LH)

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA | Conditions: Ovarian Stimulation Preceding Intrauterine Insemination | Phase 4 | Status: COMPLETED